Legal status · United States
Is Tirzepatide with BPC-157 legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Tirzepatide with BPC-157 is not an approved medicine in the United States. Its legal category is "Not approved; research use only". Nothing that contains it is allowed for any use in people. Vials labeled "for research use only" get no exception: that label does not make them legal to use in people. On the evidence, 1 completed human trial is cited on its profile.
- People given it
- 0
- Found nothing
- 0
Legal category
Not approved; research use only
Tirzepatide is FDA approved. BPC-157 is not approved, and pharmacies cannot legally mix it. So any premixed product is illegal because of the BPC-157.
Reviewed Sep 2026. This is a legal category, not legal advice.
A "research use only" label on a vial does not make it legal to use on people.
Tirzepatide with BPC-157 in the United States at a glance
| Legal category | Not approved; research use only |
|---|---|
| Note | Tirzepatide is FDA approved. BPC-157 is not approved, and pharmacies cannot legally mix it. So any premixed product is illegal because of the BPC-157. |
| FDA approval status | Tirzepatide is approved. BPC-157 is not approved. FDA staff reviewed it in July 2026 and found no adequate human data, and pharmacies are not allowed to mix it. The combination has never been reviewed. |
| Studies in people | 1 of 4 sources on the profile |
| Reviewed | Sep 2026 |
The legal category and note come from the Tirzepatide with BPC-157 profile. We checked them against U.S. Food and Drug Administration (FDA) listings on the reviewed date.
What this means
- 01
No product containing Tirzepatide with BPC-157 is approved by FDA for any use in the United States. So nothing on sale is allowed for use in people.
- 02
"Research use only" is a label sellers put on. It is not a legal category that allows use in people, and it does not get a product out of medicines law.
- 03
Importing it, supplying it or promoting it for use in people can fall under medicines law in the United States. This page is general information, not legal advice.
What Tirzepatide with BPC-157 is
The same pairing idea as the semaglutide version. One side has a bigger weight loss effect. The other side is just as empty. Tirzepatide 15 mg cut weight by 20.9% on average at 72 weeks. BPC-157 has five studies in people with under 110 people in all, and none gave it the way it is used here. Nobody has studied the pair. US pharmacies are not allowed to make BPC-157.
Tirzepatide works so well that the muscle question gets sharper than with semaglutide. In the big SURMOUNT-1 study, 57% of people on 15 mg lost 20% or more of their body weight over 72 weeks.
How it works: Tirzepatide copies two gut hormones, GIP and GLP-1. It turns down appetite and slows how fast the stomach empties.
Approval history: Tirzepatide is approved. BPC-157 is not approved. FDA staff reviewed it in July 2026 and found no adequate human data, and pharmacies are not allowed to mix it. The combination has never been reviewed.
How FDA treats this kind of product
Approves prescription drugs, each for a named use. It also acts against unapproved products, including peptides sold online. Compounding pharmacies, which mix drugs to order, may make some compounds with a prescription. That only applies when the FDA puts the compound in a category of bulk ingredients it allows.
The legal category above is how The Longevity Archive reads U.S. Food and Drug Administration listings for Tirzepatide with BPC-157 on the reviewed date. It is not a legal opinion. Rules change. Bringing a compound into the country, prescribing it and owning it can each be treated differently. Check with the agency before you act on anything here.
Tirzepatide with BPC-157 in sport and the military
Whether Tirzepatide with BPC-157 is banned in sport is set by the World Anti-Doping Code and by military rules, not by its legal status in the United States. Before you compete or get tested, look up Tirzepatide with BPC-157 by name on the Prohibited List, or look up a named product in Global DRO. Under the World Anti-Doping Code, category S0 bans, at all times, any drug-like substance that meets two tests. No other section of the List covers it. And no government health regulator anywhere has a current approval for it as a treatment in people. Many substances that are approved somewhere are banned by name in another section. So approval does not mean a substance is allowed in sport.
- WADA Prohibited List
- Global DRO (check a named product)
- USADA (US athletes)
- Operation Supplement Safety (US service members)
The rules you compete or serve under decide this, not this page.
Tirzepatide with BPC-157 in other countries
Frequently asked questions
Is Tirzepatide with BPC-157 legal in the United States?
No. Tirzepatide with BPC-157 is not an approved medicine in the United States. Its legal category is "Not approved; research use only". Nothing that contains it is allowed for any use in people. Vials labeled "for research use only" get no exception: that label does not make them legal to use in people. On the evidence, 1 completed human trial is cited on its profile. Note: Tirzepatide is FDA approved. BPC-157 is not approved, and pharmacies cannot legally mix it. So any premixed product is illegal because of the BPC-157.
Can I buy Tirzepatide with BPC-157 in the United States?
There is no approved product to buy. In the United States, Tirzepatide with BPC-157 has the legal category "Not approved; research use only". So no licensed pharmacy product exists. Sellers who list it "for research use only" are not selling it for use in people, and that label does not change its legal status. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything. Note: Tirzepatide is FDA approved. BPC-157 is not approved, and pharmacies cannot legally mix it. So any premixed product is illegal because of the BPC-157.
Is Tirzepatide with BPC-157 FDA approved?
No. FDA status: Tirzepatide is approved. BPC-157 is not approved. FDA staff reviewed it in July 2026 and found no adequate human data, and pharmacies are not allowed to mix it. The combination has never been reviewed.. Current US legal category: "Not approved; research use only". On the evidence, 1 completed human trial is cited on its profile.
Related compounds in the United States
Full research profile
How Tirzepatide with BPC-157 works, the studies we cite, FDA status and the full legal summary are all on its compound profile.
Tirzepatide with BPC-157 profileThis page is general information about the legal status of Tirzepatide with BPC-157 in the United States, current as of Sep 2026. It is not legal advice. Legal status changes. For your own situation, check with U.S. Food and Drug Administration or ask a lawyer. Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.